Drug Discovery World

MAY 30, 2023

From antibody-drug conjugates and RNA, to CRISPR and CAR-T therapy, DDW asked the drug discovery industry what the most important development in oncology over the last five years has been. We expect this field to grow significantly in the coming years as these and other earlier stage assets are developed. Here are their answers.

Research 52

Research Drugs Protein RNA 52

Drug Discovery World

OCTOBER 16, 2023

A company within this ecosystem is STORM Therapeutics, a clinical stage biotechnology company creating novel small molecule therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. These leading UK centers are in London, Edinburgh, Birmingham, and Dundee in addition to eight French centers.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. Xtalks has hosted some excellent webinars on navigating development and operations during the current pandemic, presented by leading experts in the pharmaceutical, biotechnology and food industries.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92